Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sutro Biopharma (STRO) Return on Invested Capital (2022 - 2025)

Historic Return on Invested Capital for Sutro Biopharma (STRO) over the last 4 years, with Q3 2025 value amounting to 3.15%.

  • Sutro Biopharma's Return on Invested Capital rose 42900.0% to 3.15% in Q3 2025 from the same period last year, while for Sep 2025 it was 3.15%, marking a year-over-year increase of 42900.0%. This contributed to the annual value of 2.43% for FY2024, which is 18700.0% down from last year.
  • Sutro Biopharma's Return on Invested Capital amounted to 3.15% in Q3 2025, which was up 42900.0% from 7.17% recorded in Q2 2025.
  • Sutro Biopharma's 5-year Return on Invested Capital high stood at 7.17% for Q2 2025, and its period low was 3.31% during Q4 2024.
  • Over the past 4 years, Sutro Biopharma's median Return on Invested Capital value was 0.83% (recorded in 2023), while the average stood at 0.07%.
  • As far as peak fluctuations go, Sutro Biopharma's Return on Invested Capital plummeted by -25200bps in 2024, and later soared by 81600bps in 2025.
  • Over the past 4 years, Sutro Biopharma's Return on Invested Capital (Quarter) stood at 0.56% in 2022, then plummeted by -41bps to 0.79% in 2023, then plummeted by -320bps to 3.31% in 2024, then soared by 195bps to 3.15% in 2025.
  • Its Return on Invested Capital was 3.15% in Q3 2025, compared to 7.17% in Q2 2025 and 3.31% in Q4 2024.